Page 49 - EJMO-9-3
P. 49

Eurasian Journal of
            Medicine and Oncology                                                  NOTCH3 in CSVD and breast cancer



              NOTCH3     can   enhance  chemo-sensitivity  in  participates in the regulation of satellite cells, which are
            doxorubicin-resistant BC by negatively regulating   stem cells responsible for the repair of skeletal muscle.
            Fra1, a critical factor in the EMT of BC cell lines. 80,123  In   A recent study demonstrated that mice lacking NOTCH3
            doxorubicin-resistant BC cells, Fra1 was notably over-  exhibited significantly greater muscle growth than their
            expressed while NOTCH3 was under-expressed. This   wild-type counterparts following repeated injuries, which
            resistance was attributed to the EMT induced by Fra1. It   was attributed to the increased proliferation of activated
                                                                         128
            was  possible  to induce  Adriamycin  chemo-resistance  in   satellite cells.  In contrast, NOTCH1 has been associated
            initially chemo-sensitive cells by suppressing NOTCH3   with promoting satellite cell activation and proliferation. 129
            signalling.  Apart  from that, the  stromal cells can also
                    80
            further enhance chemo-resistance by stimulating the   7.1. NOTCH3 gene aberration and risk for ischemic
            expression of NOTCH3 in BC cells, an effect that can   stroke
            be counteracted with NOTCH3 siRNA or a  γ-secretase   The exact pathophysiological mechanisms responsible
            inhibitor  (GSI).   Another  mechanism  by  which  cancer   for ischemic  stroke and its various  subtypes remain
                         110
            cells resist treatment is through a state of tumour dormancy.   incompletely understood. A  combination of genetic and
            Activation of the NOTCH3 pathway induces cell cycle   environmental factors probably contributes to the onset and
            arrest at the G0/G1 phase and promotes the expression   progression of the condition.  The NOTCH3 gene is in the
                                                                                      130
            of DNp63a, Mix1 and Hes1 proteins, which encourage   19p13.12 region, spanning from 15,159,633 base pairs to
            cellular quiescence. 124                           15,200,981 base pairs. It comprises 33 exons and 32 introns
                                                               and encodes a protein consisting of 2,321 amino acids,
              Given the constrained effectiveness of immunotherapy                                      131
            directed solely at tumour cells in BC, it becomes crucial   which plays a critical role in neuronal development.  The
                                                               NOTCH3 gene variants, rs1044009 (g.45022C > T, c.6668C
            to comprehend the regulatory function of NOTCH3    > T, p. Ala2223Val), and rs3815188 (g.13568C > T, c.303C
            signalling in the interactions between cancer cells and   > T, p. Thr101=), correspond to a missense mutation and
            immune cells within the TME across various subtypes of   a synonymous variant, respectively. Both polymorphisms
            BC. This understanding can facilitate the identification of   are situated within the intracellular DUF3454 domain of
            more effective drug targets involving NOTCH3 signalling   the protein, and they have a direct impact on the signal
            and immune cells.                                  transduction activity of NOTCH3. However,  NOTCH3

            7. NOTCH3 and the brain                            rs1043994 (g.13949A > G, c.606A > G, p. Ala202=) is a
                                                               benign point mutation or synonymous variant situated
            A previous study reported that adult mice with NOTCH3   in  the  conserved  protein  family  of  the  calcium-binding
            deficiency exhibit ongoing progressive symptoms in the   endothelial growth factor (EGF)-like domain within the
            vasculature of the brain and retina, stemming from VSMC   NOTCH3 protein. 132
            degeneration and loss through apoptosis. 125  This leads to
            a breakdown in vessel integrity, causing haemorrhaging   Certain  mutations  in  the  NOTCH3  gene  have  been
            and impairing the functionality of the blood–brain barrier   documented as a direct cause of CADASIL, an autosomal
                                                               dominant disorder affecting cerebral small penetrating
            (BBB). Furthermore, the expression of NOTCH3 in    vessels. It presents typical clinical symptoms such as
            VSMCs contributes to the regulation of vascular tone and   migraine with aura, recurrent ischemic strokes in early to
            flow-mediated dilation in both cerebral and tail resistance   middle adulthood, apathy, neuropsychological symptoms
            arteries in mice.  Moreover, the functions of NOTCH3   and cognitive impairment that advances to dementia.
                         125
                                                                                                            132
            may extend beyond vascular roles, whereby recent research   The details on NOTCH3 gene aberration and its roles in
            has reported its involvement in neuronal stem cells and   ischemic strokes and CSVD will be discussed in the later
            neuronal differentiation. 126                      section.
              The subependymal zone serves as a crucial stem
            cell niche  within the adult mammalian brain, housing   7.2. NOTCH3 and inherited cause of CSVD
            both active and dormant stem cell populations. There   However, as far back as the 1970s, literature documented
            is a distinct functional difference between NOTCH1   families who, despite lacking typical vascular risk factors,
            and NOTCH3 in the regulation of these populations. In   exhibited a heightened susceptibility to CSVD. Studies
            mouse model studies, NOTCH1 is expressed in active   reported cases of families in which multiple-infarct
            stem cells, stimulating their proliferation. On the other   dementia afflicted individuals in a manner consistent with
            hand, NOTCH3 is primarily expressed in quiescent stem   autosomal-dominant inheritance. 133,134  The prevalence of
            cells, and its role is essential for maintaining these cells by   deep white-matter lesions in these individuals indicated
            inhibiting their proliferation.  Apart from that, NOTCH3   that they were likely influenced by a genetic factor causing
                                   127

            Volume 9 Issue 3 (2025)                         41                         doi: 10.36922/EJMO025150095
   44   45   46   47   48   49   50   51   52   53   54